Aims: To identify novel pathogenic gene of febrile seizures (FS)/epilepsy with antecedent FS (EFS+).Methods: The trio‐based whole‐exome sequencing was performed in a cohort of 462 cases with FS/EFS+. Silico programs, sequence alignment, and protein modeling were used to predict the damaging of variants. Statistical testing was performed to analyze gene‐based burden of variants.Results: Five heterozygous missense variants in CELSR3 were detected in five cases (families) with eight individuals (five females, three males) affected. Two variants were de novo, and three were identified in families with more than one individual affected. All the variants were predicted to be damaging in silico tools. Protein modeling showed that the variants resulted in disappearance of multiple hydrogen bonds and one disulfide bond, which potentially caused functional impairments of protein. The frequency of CELSR3 variants identified in this study was significantly higher than that in controls. All affected individuals were diagnosed with FS/EFS+, including six patients with FS and two patients with EFS+. All cases presented favorable outcomes without neurodevelopmental disorders.Conclusions: CELSR3 variants are potentially associated with FS/EFS+.
YWHAZ encodes an adapter protein 14–3-3ζ, which is involved in many signaling pathways that control cellular proliferation, migration and differentiation. It has not been definitely correlated to any phenotype in OMIM. To investigate the role of YWHAZ gene in intellectual disability and global developmental delay, we conducted whole-exon sequencing in all of the available members from a large three-generation family and we discovered that a novel variant of the YWHAZ gene was associated with intellectual disability and global developmental delay. This variant is a missense mutation of YWHAZ, p.Lys49Asn/c.147A > T, which was found in all affected members but not found in other unaffected members. We also conducted computational modeling and knockdown/knockin with Drosophila to confirm the role of the YWHAZ variant in intellectual disability. Computational modeling showed that the binding energy was increased in the mutated protein combining with the ligand indicating that the c147A > T variation was a loss-of-function variant. Cognitive defects and mushroom body morphological abnormalities were observed in YWHAZ c.147A > T knockin flies. The YWHAZ knockdown flies also manifested serious cognitive defects with hyperactivity behaviors, which is consistent with the clinical features. Our clinical and experimental results consistently suggested that YWHAZ was a novel intellectual disability pathogenic gene.
20 April 2023 in Frontiers in Molecular Neuroscience
Introduction: With the advent of trio-based whole-exome sequencing, the identification of epilepsy candidate genes has become easier, resulting in a large number of potential genes that need to be validated in a whole-organism context. However, conducting animal experiments systematically and efficiently remains a challenge due to their laborious and time-consuming nature. This study aims to develop optimized strategies for validating epilepsy candidate genes using theDrosophilamodel.Methods: This study incorporate behavior, morphology, and electrophysiology for genetic manipulation and phenotypic examination. We utilized the Gal4/UAS system in combination with RNAi techniques to generate loss-of-function models. We performed a range of behavioral tests, including two previously unreported seizure phenotypes, to evaluate the seizure behavior of mutant and wild-type flies. We used Gal4/UAS-mGFP flies to observe the morphological alterations in the brain under a confocal microscope. We also implemented patch-clamp recordings, including a novel electrophysiological method for studying synapse function and improved methods for recording action potential currents and spontaneous EPSCs on targeted neurons.Results: We applied different techniques or methods mentioned above to investigate four epilepsy-associated genes, namelyTango14,Klp3A,Cac, andSbf, based on their genotype-phenotype correlation. Our findings showcase the feasibility and efficiency of our screening system for confirming epilepsy candidate genes in the Drosophila model.Discussion: This efficient screening system holds the potential to significantly accelerate and optimize the process of identifying epilepsy candidate genes, particularly in conjunction with trio-based whole-exome sequencing.
Epileptic encephalopathy is a common devastating epilepsy with etiologies remain largely elusive, despite application of whole gene/exon sequencing on large cohorts. This study targeted on childhood epileptic encephalopathy, typically Lennox-Gastaut syndrome that is featured by age-dependent onset and characteristic clinical manifestations. Trio-based whole-exome sequencing with individualized analysis before statistic studies was employed, including individualized analysis on each trio by explainable inheritance origin and stratified frequency filtration and on each gene from four aspects. This study identified three novel candidate genes in 235 patients, including SBF1 with de novo variants in three cases, CELSR2 with biallelic recessive variants in eight cases, and TENM1 with X-linked recessive variants in six cases. These genes presented significant repetitiveness, including significant higher excess of de novo variants in SBF1 and excess of biallelic variants in CELSR2, and aggregated frequencies of variants in SBF1, CELSR2, and TENM1. The frequency of compound heterozygous/homozygous CELSR2 variants in the cases was significantly higher than that in the asymptomatic parent-controls. Further experiments with knock-down/knock-out of these genes showed increased seizure-like behavior and increased firing of excitatory neurons. This study highlights the implication of phenotype sub-classification, individualized analysis in combination with statistic studies, and use of controls for compound heterozygous variants.